Table 2.

Clinical and genomic characteristics of study population.

Latent variables	Manifest variables	Description	Overall (n = 18)
CLI	AGE (mean ± SD)	Diagnosis age	67.1 ± 7.7
CLI	SEX (male)	Sex	8 (44.4%)
MUT	ROBO1	Candidate gene	2 (11.1%)
MUT	KAT2B	Candidate gene	2 (11.1%)
MUT	SETD1B	Candidate gene	2 (11.1%)
MUT	GNA13	Candidate gene	2 (11.1%)
MUT	APBA1	Candidate gene	2 (11.1%)
MUT	MYD88	Candidate gene	6 (33.3%)
TRX	IniRT	Initial radiotherapy	2 (11.1%)
TRX	IniST	Initial systemic treatment	13 (72.2%)
TRX	SubRT	Subsequent radiotherapy	6 (33.3%)
TRX	SubST	Subsequent systemic treatment	3 (16.7%)